Manufacturing Sites

Manufacturing Sites

State-of-the-art facilities with multi-product capabilities

Lupin’s manufacturing philosophy is simple yet strategic — we consider the needs and priorities of our key stakeholders to provide maximum impact. We are focused on innovation, and the development of safe, effective life-saving drugs for our patients. We encourage lean manufacturing and work towards eliminating inefficiencies. We facilitate teamwork and problem solving, attracting and retaining a diverse workforce. Our manufacturing footprint — 15 world-class facilities spread across India, the U.S., Brazil and Mexico — are designed to deliver the promise of caring that Lupin has come to symbolise – that no patient shall be denied access to high-quality, affordable medicines. We hold ourselves to the highest ethical standards, investing in technology, automation and modern systems to minimise human error, maintain quality and enhance profitability. The focus on manufacturing excellence allows us to maintain our pre-eminence as a leader in formulations and APIs. It has helped us achieve best-in-class standards in both manufacturing and quality operations. Click here to read the Environmental reports.


Lupin’s flagship facility, the Aurangabad plant, started operations in 1979. The facility employs ~450 people and manufactures various dosage forms like tablets, capsules and suspension in the dosage forms.

A/28/1, MIDC Industrial Area
Aurangabad – 431 210


The Ankleshwar facility started functioning in 1982 and employs close to 1000 personnel. With OSHAS 18001:20007 and ISO 14001:2004 certifications, the facility manufactures intermediates and APIs. It has also received the International Sustainability Rating System (ISRS) level 7 certification, the highest score in pharma manufacturing globally.

Plot No. 09
123, 123/1, 124, 125, GIDC Estate
Ankleshwar, Gujarat – 393 002


Established in 1986, the facility employs approximately 1150 persons. It manufactures APIs (cephalosporins and cardiovascular) and Cephalosporin Formulations. It has received the International Sustainability Rating System (ISRS) level 7 certification, the highest score in pharma manufacturing globally.

198-202, New Industrial Area No.2
Mandideep, Raisen, Madhya Pradesh – 462 046


Lupin’s Biotech facility at Pune was established in 2008 and employs 520 staff. It is involved in the Development and Commercialization of Biosimilars for Global markets. The plant has state of the art facilities for production of Biologics using Microbial and Mammalian platform technology. The facility is approved by major International Regulatory bodies from Japan, Europe and others.


Gat No. 1156, 1157, 1158, 1159 and 1160
Village Ghotawade, Taluka-Mulshi
Pune-412115, Maharashtra, India.


The plant commenced operations in 1992 and employs 1200 persons. It manufactures both fermentation-based and synthetic APIs. It has received the International Sustainability Rating System (ISRS) level 7 certification, the highest score in pharma manufacturing globally.

T-142, MIDC, Tarapur
Boisar (West), Thane
Maharashtra – 401 506


It commenced operations in 2003 and employs 900 people. It manufactures very complex formulations for over four billion units.

B-15, Phase 1A
Verna Industrial Area
Verna, Salcette
Goa – 403 722

ISO 14001
ISO 45001


The plant commenced operations in 2006. It employs more than 200 persons and manufactures Oral solid dosage as well as Inhalation formulations.

EPIP Kartholi
SIDCO Industrial Complex
Bari Brahmana, Samba
Jammu & Kashmir – 181 133


The plant commenced operations in 2007 and is manned by close to 700 employees. The facility, which has OSHAS 18001, ISO 14001 and ISO 9001 certifications, manufactures a wide range of products including pharmaceutical intermediates and APIs for domestic and international markets. It has also been certified by the International Sustainability Rating System (ISRS).

Block 21, Village Dabhasa
Ta-Padra, Vadodara – 391 440


The plant stated operations in 2007. It employs more than 1500 people. It manufactures, Potent and Oral contraceptive APIs as well as formulations of Potent products, Oral Contraceptives, Oral solid dosage, Opthals, Derma and Inhalation products.

Unit 1 & Unit 2
Plot No. 2, Special Economic Zone Phase – II
Miscellaneous Zone, Apparel Park
Pithampur, Dhar, MP- 454 775

Unit 3
Plot No. M1, Special Economic Zone
Phase – II, Miscellaneous Zone, Apparel Park
Pithampur, Dhar, MP- 454 775

ISO 14001
ISO 45001


The facility started functioning in 2013 and currently employs 900 employees. It manufactures more than eight billion units of oral solid dosage formulations. Also an Injectable facility has been commissioned.

Plot 6A, Sector 17
SEZ, MIHAN Notified area
Maharashtra – 441 108


The facility commenced operations in 2014. The facility has 200 employees and manufactures APIs.

Plot No.130, Road No.11
J.N. Pharma City, Parawada (M)
Andhra Pradesh – 531 019


Established in 2015, the plant employs 180 people and manufactures formulations of Oral solid dosage as well as Inhalation products.

4th Mile, Bhasmey
Karmarey-Bhasmey Block
Duga Iilaka, East Sikkim
Sikkim – 737 132


Laboratorios Grin was acquired in March 2014 and employs 350+ people. It manufactures specialized ophthalmic dosage and nasal forms with a volume of 10+ million units per annum.

Rodriguez Saro 630
Col. Del Valle
Alcaldía Benito Juarez
CP 03100
Mexico City (CDMX)


Medquimica commenced operations in 1975 and employs 550+ people. It manufactures more than 2.4 billion units of oral dosage (oral solids and oral liquids Formulations) forms per annum. It was acquired in June 2015.

255, Fernando Lamarca street
District Industrial
Juiz de Fora city
Minas Gerais State
Zip Code 36092-030


Commenced operations in 2006 and employs 300+ people. It manufactures tablet, capsule, powder and liquid oral dosage forms.

400 Campus Drive
Somerset, NJ  08873

Also Read